Modulation of Amyloid-β Fibrils into Mature Microrod-Shaped Structure by Histidine Functionalized Water-Soluble Perylene Diimide

ACS Applied Materials & Interfaces
Balakrishnan MuthurajParameswar K Iyer

Abstract

Alzheimer's disease (AD) is associated with different types of amyloid peptide aggregates including senile plaques, fibrils, protofibrils, and oligomers. Due to these difficulties, a powerful strategy is needed for the disaggregation of amyloid aggregates by modulating their self-aggregation behavior. Herein, we report a unique approach toward transforming the aggregated amyloidogenic peptides using an amino acid functionalized perylene diimide as a molecular modulator, which is a different nondestructive approach as compared to inhibiting the aggregation of peptides. The histidine functionalized perylenediimide (PDI-HIS) molecule could coassemble with amyloid β (Aβ) peptides via hydrogen bonding that leads to the enhancement in the π-π interactions between Aβ and PDI-HIS moieties. The Thioflavin T (ThT) assay and various spectroscopic and microscopic techniques establish that the PDI-HIS molecules accelerate the Aβ1-40 and the amyloid aggregates in CSF into micro size coassembled structures. These results give rise to a new and unique complementary approach for modulating the biological effects of the aggregates in amyloidogenic peptides.

References

Oct 22, 1996·Biochemistry·A R SalomonM G Zagorski
Nov 7, 1999·The Journal of Biological Chemistry·D S YangP E Fraser
Jul 25, 2000·Journal of Molecular Biology·F TagliaviniM Salmona
Mar 29, 2001·Protein Science : a Publication of the Protein Society·S Chen, R Wetzel
Oct 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·B UrbancB T Hyman
Jan 15, 2003·Biochemistry·Melanie R Nilsson, Christopher M Dobson
Mar 21, 2003·The Journal of Biological Chemistry·Tadato BanYuji Goto
Dec 14, 2004·The Journal of Biological Chemistry·Fusheng YangGregory M Cole
Jun 7, 2005·Protein Science : a Publication of the Protein Society·Peter HortschanskyMarcus Fändrich
Jun 8, 2006·Annual Review of Biochemistry·Fabrizio Chiti, Christopher M Dobson
Apr 3, 2007·Angewandte Chemie·Andrea CavalliCarlo Melchiorre
Jun 7, 2007·Nature Reviews. Neuroscience·Frank M LaFerlaSalvatore Oddo
Oct 11, 2008·The Journal of Biological Chemistry·Robin RoychaudhuriDavid B Teplow
Oct 22, 2008·Accounts of Chemical Research·Tsuyoshi Takahashi, Hisakazu Mihara
Oct 29, 2008·Journal of the American Chemical Society·Celia Cabaleiro-LagoSara Linse
Mar 31, 2009·Journal of Molecular Biology·Xiaojing MaChen Wang
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Bo ChenRobert Tycko
Nov 3, 2009·Journal of the American Chemical Society·Sarmad S HindoMi Hee Lim
Aug 2, 2011·Nature Chemical Biology·Jiyong LeeJeffery W Kelly
Sep 2, 2011·Biomacromolecules·Devin M RidgleyJustin R Barone
Nov 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Xiao-Bo MaoChen Wang
Jan 17, 2012·Journal of Molecular Biology·Torleif Härd, Christofer Lendel
Jul 4, 2012·Accounts of Chemical Research·Peter J Crouch, Kevin J Barnham
Jul 10, 2012·Biomacromolecules·Sabrina DehnSébastien Perrier
Jan 22, 2013·Journal of the American Chemical Society·Xiaobo MaoChen Wang
Jul 13, 2013·Langmuir : the ACS Journal of Surfaces and Colloids·Michele D'AmicoValeria Vetri
Nov 14, 2013·Journal of the American Chemical Society·Shelley A ClaridgePaul S Weiss
Jan 28, 2014·Journal of the American Chemical Society·Silvia CampioniRoland Riek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.